Abstract Major histocompatibility complex (MHC) class I molecules comprise a family of polymorphic cell surface receptors consisting of classical 1 a molecules that present antigenic peptides and nonclassical 1 b molecules. Gene expression for human classical and nonclassical MHC class I molecules has been shown to be differentially regulated by interferon, with variation in the nucleotide sequence of promoter regions, resulting in differences in interferon inducibility and basal levels of gene transcription. In this study on porcine classical and nonclassical swine leukocyte Ag (SLA) class I molecules, we show alignments of putative regulatory elements in the promoters of the three functional classical class I genes, SLA-1, SLA-2, and SLA-3; two nonclassical 1 b genes, SLA-6 and SLA-7; and a MIC-2 gene. Promoter elements were cloned upstream from a luciferase reporter gene, and the basal and inducible activities of each were characterized by expression in Max cells, an immortalized pig cell line that responds to interferon and tumor necrosis factor alpha (TNF-α). All three classical class I but not nonclassical promoters responded to interferon. This was confirmed by the transactivation of SLA-1, but not SLA-7, after the co expression with interferon regulatory factors (IRFs), IRF-1, IRF-2, IRF-3, IRF-7, and IRF-9. Classical class I genes were activated by cotransfection with nuclear factor kappa B (NF-κB) p65 and by treatment of cells with TNF-α, although, unlike human promoter there was no synergistic effect with interferon. The greatest effect on classical class I promoters was coexpression with the class II transactivator (CIITA), important for constitutive transactivation. These results determine the differential regulation of porcine classical and nonclassical MHC class I and reflects their importance in antigen presentation during infection.
Introduction
Major histocompatibility complex (MHC) proteins are important for binding epitopes derived from host or pathogen proteins and presenting them to T cells. In the pig, the major histocompatibility complex or swine leukocyte antigen (SLA) is located on chromosome 7, divided by the centromere (Rabin et al. 1985) . The pig MHC complex is much more compact than the human MHC; the swine class I region spans 1.1 Mb and contains 54 genes, whereas in humans, the class I region spans 1.8 Mb and contains some 80 genes Chardon et al. 1999; Vaiman et al. 1998) . Sequencing of the MHC class I region of the H01(Hp-1.1) haplotype pig has provided a more detailed understanding of gene content, intron, and exon organization and promoter structure, allowing predictions of expression to be made (Renard et al. , 2006 . Three classes of SLA class I genes have been identified: classical (or class Ia) genes, nonclassical (class Ib), and MHC class I chain-related (MIC) genes (or class Ic). In pigs, a total of seven classical SLA class I loci have been identified: SLA-1, SLA-2, SLA-3, SLA-4, SLA-5, SLA-9, and SLA-11 ). Of the class Ia genes, only SLA-1, SLA-2, and SLA-3 are known to be functional, with a classical MHC class I molecular structure that is a leader sequence, three exons encoding the extracellular α1, α2, and α3 domains, a transmembrane region, and three cytoplasmic exons.
A cluster of three nonclassical class Ib genes have been identified in the pig: SLA-6, SLA-7, and SLA-8 Renard et al. 2006) . These genes are located adjacent to the junction between the class I and III regions, approximately 500 kb upstream of the class Ia genes. SLA-6 and SLA-7 are transcribed in the same direction, whereas SLA-8 is encoded on the opposite strand. They have the nearly monomorphic characteristic of nonclassical genes in other mammals. The exact functions of SLA class Ib genes have not been determined; however, the products of the three genes are predicted to be membrane-anchored glycoproteins with the potential of binding peptides ). In the pig, only two MHC class I chain-related (MIC) class Ic sequences, MIC-1 and MIC-2, have been identified. These genes are located in close proximity to the class Ib genes.
Because of the polymorphic but homologous nature of the MHC complex, the cell surface analysis of the regulation after cell activation or infection is difficult, with monoclonal antibodies unable to distinguish between classical and nonclassical SLA antigens. The SLA region has been completely mapped and sequenced , with a DNA-based nomenclature for SLA genes and alleles (Smith et al. 2005) ; however, knowledge of the transcription, expression, and functions of the family of SLA class I genes in the pig is limited. An analysis of the promoter region of each of the gene may predict which genes are expressed. Complex regulatory elements were functionally identified in a 1-kb fragment of the 5′ flanking regions of the PD1 (SLA1) gene of the d/d H04 haplotype (Maguire et al. 1992; Frels et al. 1990 ) and consisted of tissue-specific enhancer and silencer sequences. Subsequently, the promoter regions of the SLA-1, SLA-2, and SLA-3 genes of the H01(Hp-1.1) pig were aligned with the PD1 regulatory elements . The classical SLA promoter regions contain a series of conserved, putative regulatory motifs located within distal and proximal promoter domains. This study investigated the functional regulation of these regions of classical and nonclassical genes. SLA class I gene promoter sequences were isolated from pig bacterial artificial chromosome (BAC) clones spanning the whole MHC complex. The constitutive and induced transcriptional activity was measured in cells after activation by cytokines and also after coexpression with several relevant transcription factors. This was correlated to putative regulatory motifs identified within promoter regions. The results show that classical and nonclassical SLA loci have differences in promoter activity, leading to different expression patterns, the functional significance of which may be important after cellular activation during inflammation or infection.
Materials and methods

Cells and reagents
Max cells (immortalized swine kidney cells that express the SLA d/d haplotype) were obtained from the Federal Research Centre for Virus Diseases of Animals (Tübingen, Germany) and have been described previously (Pauly et al. 1995) . Max cells were grown at 37°C in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% fetal calf serum (FCS). PT-85 is a pan-specific MHC class I antibody (VMRD, Pullman, WA, USA). The monoclonal antibodies 2.27.3a (Ivanoska et al. 1991 ), 74.11.10 (Pescovitz et al. 1984 , 2.12.3, and 2.32.1 (Lunney and Pescovitz 1988) were from hybridoma cell lines. The IRF-1 and IRF-2 expression plasmids pEFPlink2.IRF-1 and pEFPlink2.IRF-2 containing full length human complementary DNA (cDNA) encoding IRF-1 and IRF-2, respectively, and pcDNA3.1-IRF-7 containing the full length human cDNA encoding IRF-7 were provided by S Goodbourn, (St. George's Hospital Medical School, London). The IRF-3 expression plasmid containing full-length human cDNA encoding IRF-3 was provided by O. Dang and M. David (University of California, San Diego, CA, USA). The IRF-9 expression vector pcDNA3-IRF-9.vp16 encoding a constitutively active form of IRF-9 comprising the DNA-binding domain of IRF-9 fused to the transactivator domain of the HSV1 VP16 protein has been previously described (Kraus et al. 2003) . Nuclear factor kappa B (NF-κB) expression vectors pRc/CMV.p50 and pRc/CMV.p65 contain human p50 or p65 cDNAs, respectively, within the vector pRc/ CMV were from Heike Pahl, University of Freiberg. The class II transactivator (CIITA) expression vector pcDNA3.1-CIITA(1315) contains CIITA cDNA derived from human B-cells in the pcDNA3 backbone from C.-H. Chang, Indiana University School of Medicine, USA.
SLA cell surface expression (FACS analysis)
The cells were incubated with saturating amounts of primary SLA class I antibodies and stained with a fluorescent secondary antibody (Southern Biotechnology Associates). The cell surface MHC class I expression was analyzed by flow cytometry (FACScan, Becton Dickson) using the CellQuest program. The degree of cell membrane MHC class I expression was expressed as mean fluorescence intensity (MFI). For SLA activation experiments, Max cells were incubated with 200 U/ml of recombinant porcine interferon alpha (IFN-α, PBL Biomedical Labs, USA) or 0.2 μg/ml recombinant porcine interferon gamma (IFN-γ, Biosource, USA) in RPMI or IMDM, respectively, for 16 h at 37°C.
SLA class I promoter cloning from bacterial artificial chromosomes
The bacterial artificial chromosomes (BACs) 207G8, 490B10, and 493A6 were derived from a library comprising some 107,000 clones that span the entire haploid genome of a male, Large White pig homozygous for the MHC H01 haplotype (Velten et al. 1999; Rogel Gaillard et al. 1999) . The European Molecular Biology Laboratory (EMBL) accession numbers for BACs are AJ251829 (207G8), AJ131112 (490B10), and AJ251914 (493A6). The screening of the entire BAC library using primers designed for amplification of conserved regions of MHC class I sequences (exons 1 to 4) identified 18 BAC clones containing SLA class I genes (Velten et al. 1999) . The primers to amplify the promoter sequences were designed with terminal NheI and HindIII sites and, complimentary sequences were selected that permit cloning of the entire promoter region of each SLA class I gene, from the 5′ upstream distal enhancer sites to the ATG site . The primers used for the amplification of each SLA class I promoter region are shown in Table 1 . The PCR reaction was carried out for 30 cycles of 94°C for 30 s, annealing according to Tm extention at 72°C for 1 min/kb. The sizes of the DNA isolated are shown in Table 1 for each SLA promoter. The PCR products were cloned into the T-tailed vector pcDNA3.1/V5-His/TOPO (Invitrogen), following the manufacturer's protocol. The clones of each construct were sequenced and compared to the reference BAC sequences. DNA excised from this vector was ligated into pGL3Basic (Promega). SLA-1, SLA-2, SLA-3, SLA-6, SLA-7, and MIC-2 genes were successfully ligated into pGL3-basic.
Transfections
Max cells were transfected with SLA promoter-luciferase reporter plasmid DNA using cationic lipofectamine liposomes (Invitrogen, UK) at a ratio of 1 μg plasmid DNA to 2.5 μl lipofectamine. In cotransfection experiments, transcription factor expression vectors were titrated to give optimal luciferase activity and included pEFPlink2.IRF-1, pEFPlink2.IRF-2, pcDNA3-IRF-3, pcDNA-IRF-7, pcDNA3-IRF-9.vp16, pRc/CMV.p50, pRc/CMV.p65, or pcDNA3.CIITA(1315). For control experiments, 0.5 μg of the following control plasmids was used: pGL3-control, p (9-27 ISRE)4tkΔ(−39)Lucter, p(IRF-1*GAS)6tkΔ(−39) Lucter, pkB6tkluc, p[(AAGTGA)4]5tkΔ(−39)Lucter. A positive control for luciferase activity was pGL3-control vector (Promega) containing the firefly luciferase gene under the control of SV40 promoter and enhancer sequences. Luciferase assays were performed using the luciferase substrate (Promega), following the manufacturer's instructions. pJATLacZ, a β-galactosidase reporter gene under the control of the rat β-actin promoter (Didcock et al. 1999) , was used as a control for transfection efficiency and the normalization of luciferase assay data. For cytokine activation experiments, the cells were treated with 0.5-μg/ ml recombinant human tumor necrosis factor alpha (TNF-α, R&D Systems, USA) in IMDM, respectively, for 12-16 h at 37°C or with IFN-α or IFN-γ as described above. The control plasmid for IFN-α was reporter plasmid p(9-27 ISRE)4tkΔ(−39)lucter containing four copies of the interferon-stimulated response-element (ISRE) consensus sequence (AGGAAATAGAAACTG) arranged in tandem upstream of the firefly luciferase reporter gene (Reid et al. 1989; King and Goodbourn 1998) . For IFN gamma, the reporter plasmid p(IRF-1*GAS)6tkΔ(−39)lucter with six copies of the gamma-activated sequence (GAS) consensus sequence (TTTCCCCGAAA) arranged in tandem upstream of the firefly luciferase reporter gene Goodbourn 1994, 1998) . A positive control to monitor cellular responses to TNF-α and NF-κB p65 cotransfection, pκB6tkluc, contained six NF-κB binding sites upstream of the luciferase gene under the control of the herpes simplex thymidine kinase promoter. A control reporter p[(AAGTGA)4] 5tkΔ(−39)lucter (HEX-4) was used to monitor IRF-1 activity. This plasmid contains a luciferase gene under the control of a synthetic promoter containing the herpes simplex virus thymidine kinase TATA box and five tandem repeats of an IRF-1 and IRF-2 binding sequence (AAGTGA).
Results
Cell surface expression of SLA class I molecules
The response of SLA class I surface expression to interferons was studied in Max cells, an immortalized cell line originally isolated from the d/d haplotype pig (Pauly et al. 1995) . Surface staining with three pan-or haplotypespecific antibodies, PT-85, 2.27.3a, and 2.12.3, detected high constitutive levels of SLA class I on these cells (Fig. 1) . Both IFN-α (left panel) and IFN-γ (right panel) increased cell surface SLA class I expression. The expression of the epitope recognized by PT-85 was more weakly induced by IFNs than the epitopes recognized by 2.27.3 and 2.32.1. The epitope recognized by a fourth haplotype-specific antibody, 2.12.3, was not constitutively expressed on Max cells but was highly induced after IFN treatment (Fig. 1) . Overall, SLA class I was induced to a greater extent by IFN-γ than IFN-α. In vivo, IFN-γ secreted from activated T cells is an effective inducer of MHC class I during cellular activation. These results show that transformed Max cells can respond to IFN-α and IFN-γ by up regulating the SLA class I gene expression through their interferonsensitive promoter regions.
Identification and cloning of SLA 1 promoter regions To correlate the cell surface expression with the regulation of SLA class I expression, the promoter elements of classical and nonclassical SLA genes were isolated from porcine DNA. A diagram of the swine MHC located on chromosome 7 is shown ( Fig. 2a ; Chardon et al. 2001; Renard et al. 2001) . It is divided into three regions according to gene content: class II, class III, and class I regions. The position of the centromere is indicated by a circle. The regions containing postulated open reading frames for SLA class I are shown (dark boxes), SLA class II genes are shown as hash boxes, and other functional genes of interest are shown as open boxes. A series of overlapping bacterial artificial chromosomes (BACs) that span the entire MHC class I locus of a single haplotype pig (H01) have been sequenced and characterized . Three BACs were identified, which among other genes, collectively contain all of the SLA class I genes. BAC 207G8 contained the class Ia gene SLA-1. BAC 490B10 contained the class Ia genes SLA-2 and SLA-3, the putative class Ia gene SLA-5 and the pseudogenes SLA-4, SLA-9, and SLA-11. BAC 493A6 contained the class Ib genes SLA-6, SLA-7, and SLA-8, and the class Ic gene MIC-2. The content and physical organization of the genes identified within each BAC is shown (Fig. 2b) . Individual genes are shown as solid arrows, and hatched arrows indicate pseudogenes.
Constitutive and cytokine-induced activation of SLA class I promoters
The upstream promoter elements of the classical genes SLA-1, SLA-2, and SLA-3, and the nonclassical SLA-6 and SLA-7, and MIC-2 were cloned from the distal enhancer silencer sites to the translation initiation sites ( Fig. 2c ; Chardon et al. 2001; Renard et al. 2001 ) using the primers shown in Table 1 . The SLA-5 and SLA-8 regulatory elements were not tested. The promoter sequences of all the SLAs are presented in Fig. 2d , showing a comparison of the conservation of the nucleotide sequences. Short interspersed nuclear element (SINE) elements within the promoter regions of SLA-2 and SLA-3 have been excluded from the alignment. Conserved regulatory domains compared to mouse and human are boxed. A series of regulatory domains were identified within the 5′ flanking regions of SLA class I genes, including several distal enhancer silencer sites, a region homologous to that found in mouse H-2 k, and an enhancer. In addition, a proximal domain was identified containing functional motifs implicated in cytokine-induced regulation of human leukocyte antigen (HLA) expression, including two putative Sp1 binding sites, an enhancer A region containing putative binding sites for NF-κB family transcription factors, and an ISRE region that may bind IRF-1 and IRF-2. A class I transactivator region containing W/S, X, and Y elements was deduced from comparison of SLA promoters with other vertebrate class I and class II promoter sequences that have already been characterized (van den ).
In Fig. 3 , SLA promoter sequences were aligned with published human promoter regions of HLA-A, HLA-B7, and HLA-Cw7 to compare the locus-specific variation of human (Johnson 2003) with pig. Because SLA-1, SLA-2, and SLA-3 share highly homologous sequences in enhancer A, ISRE, and SXY domains, only SLA-1 is shown here Renard et al. 2001 ).
The constitutive activity of SLA-1, SLA-2, SLA-3, SLA-6, SLA-7, and MIC-2 promoters was determined by transfecting cDNAs for each promoter cloned upstream of a luciferase reporter gene into Max cells (Fig. 4) . As a control for transfection efficiency, the cells were cotransfected with the plasmid pJATLacZ, a β-galactosidase reporter gene under the control of the rat β-actin promoter (Didcock et al. 1999 ).
Both classical and nonclassical promoters were constitutively active. Relatively, SLA-1 was most active of the three classical SLA promoters, SLA-2 was less, and SLA-3 activity was low. Of the nonclassical promoters, SLA-7 was most active at approximately two times that observed for SLA-1, whereas SLA 6 promoter constitutive activity was lower, similar to SLA 1. MIC-2 had an activity comparable to SLA-2.
The cytokine-induced activity was measured after the treatment of cells with interferon and TNF-α (Fig. 5) (King and Goodbourn 1998; Reid et al. 1989 ). The control reporter plasmid for IFN-γ treatment was pGAS, containing two copies of the IRF-1 GAS promoter site consensus sequence Goodbourn 1994, 1998) The treatment of cells transfected with pISRE with IFN-α and cells transfected with pGAS with IFN-γ increased luciferase synthesis by 3.2-and 2.1-fold, respectively ( Fig. 5a and b, control). Interestingly, there was a significant decrease in pGL3-control plasmid with an SV40 early promoter when treated with IFN-α (Fig. 5a, pGL3 con), possibly due to induction of the RNA-dependent protein kinase, PKR, activity. Therefore, the IFN was titrated to find a dose where this was minimized but induction of activity was observed. IFN-γ also caused a decrease in luciferase production by pGL3-control (Fig. 5b ), but as a weaker inducer of PKR, the decrease in the constitutive luciferase activity of pGL3-control was less than the decrease observed with IFN-α. IFN-γ induced the promoter activities of all three classical promoter, SLA-1, SLA-2, and SLA-3 (Fig. 5b) , with the SLA-1 promoter showing a relatively greater increase. There was no response of the SLA-6 promoter to either IFN-α or IFN-γ (Fig. 5) . A slight repression of SLA-7 and MIC-2 was observed, probably due to induction of PKR activity and inhibition of translation as seen for the control plasmids. The response of a representative classical gene, SLA-1, and a nonclassical gene, SLA-7, to the proinflammatory cytokine TNF-α was investigated (Fig. 5c ). TNF-α treatment resulted in a twofold induction of the SLA-1 promoter but a smaller increase of 1.3-fold induction for the SLA-7 promoter (Fig. 5c ). The control plasmid was not affected by TNF-α. The synergistic effect of TNF-α and IFNs on the SLA-1 and SLA-7 promoter expression was investigated. Unlike the case for human HLA promoters (Johnson 2003) , there was no synergistic effect of TNF-α and IFNs. This may reflect the large size of upstream regulatory element tested for these genes, and a more specific effect may be seen using the enhancer areas alone. Again, IFN treatment showed an inhibition of luciferase activity from control plasmids, possibly due to induction of PKR.
Transcription factors activating SLA class I promoters ISRE were found within all SLA class I promoters with the exception of MIC-2 and SLA-8. An analysis of the nucleotide sequence of the of ISRE element for SLA-1, SLA-2, SLA-3, SLA-6, and SLA-7, and a comparison with HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, and HLA-G is shown in Fig. 6 . It revealed that the ISREs of SLA-1, SLA-2, and SLA-3 are identical to the ISRE of HLA-A1 and C. By contrast, the sequences of ISRE in nonclassical SLA-6 and SLA-7 promoters differ from the three human homologous nonclassical genes, HLA-E, HLA-F, and HLA-G. However, the ISRE of SLA-7 is very similar to that of classical SLA and HLA, but with three nucleotide variations up-and downstream of the consensus IRF-binding motif. SLA6 has a two-nucleotide insertion compared to other genes. Functional analysis of the ISRE element was carried out by expressing SLA-1 and SLA-7 promoter constructs with cDNAs for several members of the IRF family, including IRF1, IRF2, IRF3, IRF7, and IRF9 (Fig. 6b) . A control reporter p[(AAGTGA)4]5tkΔ(−39)]lucter was used to monitor IRF-1 and IRF-2 activity. This plasmid contains a luciferase gene under the control of a synthetic promoter containing the herpes simplex virus thymidine kinase TATA box and five tandem repeats of an IRF-1/2-binding motif. Cotransfection of IRF-1 with the positive control vector results in a 4.7-fold increase in the transcription of the luciferase gene. Transcriptional activity of the SLA-1 promoter was induced by IRF-1 by 1.6-fold and to the same extent by cotransfection of IRF-2 (Fig. 6b) . Interestingly, a 1.4-fold induction of SLA-7 by IRF-1 was observed, although there was no effect when cells were transfected with IRF-2. This is in contrast to the lack of interferon responsiveness of the SLA-7 promoter when cells were treated with interferon (Fig. 5) . The effect of the expression of IRF-3, IRF-7, and IRF-9 on SLA class I promoters was investigated (Fig. 6b) . IRF-3 binds in a complex to the same site as IRF-1 and IRF-2. Cotransfection with IRF-3 induced SLA-1 promoter activity by 2.9-fold. However, IRF-3 had no significant effect on the SLA-7 promoter. Cotransfection with IRF-7 induced SLA-1 transcription by 1.9-fold but not SLA-7 transcription (Fig. 6b) . IRF-9 stimulates transcription of IFN-stimulated genes (ISGs) only as part of a complex with STAT1 and STAT2. A constitutively active IRF-9 fusion protein combining IRF-9 with the transactivator domain of the HSV1 VP16 protein induced SLA-1 promoter activity by 2.9-fold and SLA-7 weakly by 1.5-fold. In summary, the classical SLA1 promoter activity was stimulated by all five IRFs. The nonclassical SLA-7, although possessing a similar ISRE consensus sequence AGTTTCNNCNY found in IFNinducible gene, promoters showed only a slight response to IRF1 and IRF-9.
Putative NF-κB binding sites were identified within the enhancer A regions of all SLA class I promoters with the exception of MIC-2 (Fig. 7) . Classical SLA promoters differ from human classical enhancer A sequences at the seventh base from T to G. Enhancer A sequences of nonclassical SLA-6 and SLA-8 promoters were identical to R Fig. 2 Physical structure of SLA regions on chromosome 7 and characterization of SLA class I gene promoter sequences isolated from BACs. a The MHC class I locus of the pig is located on chromosome 7 of the pig. The class I region contains SLA class Ia, Ib, and Ic genes (dark boxes). The class II region contains SLA class II genes (light boxes). Other functional genes of interest are depicted as open boxes. b Three BACs contained all of the SLA class I genes. BAC 493A7 included the nonclassical class Ib genes SLA-6, SLA-7, SLA-8, and the class Ic gene MIC-2. BAC 490B10 contained the classical class Ia genes SLA-2 and SLA-3; the putative class Ia gene SLA-5; and three pseudogenes, SLA-11, SLA-4, and SLA-9. BAC 207G8 included a single class Ia gene SLA-1. Clones 490B10 and 207G8 have been shown by sequencing to be continuous, and so, no additional class I genes exist in this H01 haplotype. The genes that may be functional are shown (shaded boxes); pseudogenes are shown as hatched boxes. Arrows designate the direction of transcription. c BAC sequence data were used to design primers for the amplification of the full length promoter regions of SLA-1, SLA-2, SLA-3, SLA-6, SLA-7, SLA-8, and MIC-2 genes (circles). The beginning and end nucleotide used to amplify the promoter region is shown on each BAC (rectangles). d The alignment of the SLA promoter regions for SLAs 1-8 reveal a series of conserved regulatory domains in class Ia and Ib genes. These include a distal domain containing enhancer and silencer sites, and a proximal domain containing a region homologous to a functional motif within the mouse H-2 k gene, a proximal enhancer, two putative Sp1 binding sites, an enhancer A, and an interferon-stimulated response element (ISRE). Also, present in the proximal domain are three transactivator elements common to MHC class I, class II, and b2-microglobulin promoters, w, x1, and y. A series of proximal or "core" elements including CAT and TATA boxes and a CAP-binding motif are also present each other and share homology with their human counterparts with T as the seventh base; however, both have a change from C to T as the tenth base. SLA-7 promoter has a two-base pair deletion. The functional activity was determined by coexpression with NF-κB p65. The classical SLA promoters were induced, whereas nonclassical enhancers were not. This showed that the putative enhancer A sequences identified within classical SLA promoters are regulated by NF-κB p65, but despite having similar enhancer A sequences to those reported in classical and HLA class I promoters, the nonclassical promoters are not. This confirmed the results in Fig. 3 Alignment of porcine SLA-1 promoter sequence with human HLA-A1, HLA-B7, and HLA-Cw7 alleles. The 5′-flanking sequence of SLA class Ia share homology with human class I a genes within regions containing functional motifs including enhancer A, ISRE, w/s, x, and y domains (boxes). Consensus sites for each motif are indicated underneath not SLA-7 was induced by treatment of cells with TNF-α. Cotransfection with NF-κB p50 had no positive effect on promoter activity for either classical or nonclassical promoters and may have had slightly repressive effect on transcription, as has been reported previously (Plaksin et al. 1993 ).
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Regulation of SLA promoters by CIITA An alignment of human and porcine S, X, and Y modules within classical and nonclassical promoters was performed (Fig. 8a) . Classical SLA S, X, and Y elements are highly homologous to each other, and those found in human classical promoters. Nonclassical S, X, and Y elements are less homologous to each other but do share homology with human nonclassical S, X, and Y. In particular, the S and X1 regions of the SLA-7 promoter are noticeably different. The effect of CIITA on SXY regulatory domains in SLA class I genes was investigated. The promoter reporter constructs SLA-1, SLA-2, SLA-3, SLA-6, SLA-7, and MIC-2 were cotransfected with the CIITA expression vector (Fig. 8b) . The classical SLA promoters, SLA-1, was induced by 4.9-fold on cotransfection with CIITA. Similarly, CIITA also induced SLA-2 and SLA-3 by 5.4-and 3.3-fold, respectively, and confirm that the putative S, X, and Y regulatory modules identified within classical SLA promoters are functional and, as with human classical promoters, are regulated by CIITA. For the nonclassical SLA promoters, CIITA expression did not affect the SLA-6 and SLA7 promoters, reflecting differences in the sequence of the S, X, and Y module. Sequence differences in the S and X regions and, particularly, in the X2/site-a Á region of SLA-7 may provide a partial explanation for the lack of CIITA activation.
Discussion
The analysis of the expression of different classical and nonclassical SLA class I molecules on the cell surface is complicated by their polymorphic nature. The monoclonal antibody PT-85 has the broadest specificity, recognizing a highly conserved epitope within the MHC class I molecule in a range of species. The porcine-specific antibody 2.27.3 is serologically defined as poly-loci specific and recognizes a common determinant shared among the pig haplotypes H04, (Satz and Singer 1984) . We used these antibodies to show that Max cells respond to interferon by upregulation of SLA class I surface expression. In addition, we found that IFN-γ was a more potent inducer of cell surface expression than IFN-α. This correlates with in vivo importance of IFN-γ in SLA class I responses, where recognition of an antigen presenting cells by cytotoxic Tlymphocytes promotes secretion of IFN-γ, up regulating the expression of classical SLA class I molecules on the surface of the presenting cell.
Our study compared the expression of the different classical and nonclassical molecules at the level of gene transcription. Promoter sequences from pig genes were compared with HLA 5′ flanking regions to identify the whole of the regulatory region for six SLA class I genes, including classical genes SLA-1, SLA-2, and SLA-3, nonclassical genes SLA-6 and SLA-7, and the class Ic gene MIC-2. The human MHC class I promoter comprises a series of regulatory elements, the impact of which on promoter activity has been well characterized (van den Elsen et al. 2004 ). The distal domain contains enhancer and silencer sites. The proximal domain contained a region homologous to a functional motif within the human HLA gene, a proximal enhancer, an enhancer A, and an interferon-stimulated response element (ISRE). In addition, the proximal domain contains regulatory elements common to MHC class I, class II, and β2-microglobulin promoters, namely three transactivator elements W/S, X, and Y (van den , and also a series of proximal or "core" elements including CAT and TATA boxes and a CAP-binding motif. Our comparison of individual SLA class I promoter sequences revealed locus-specific differences in promoter elements that may be responsible for differential levels of constitutive and cytokine-induced expression of the individual SLA class I genes. The functional motifs within SLA-1, SLA-2 and SLA-3 promoters are highly conserved, whereas those of nonclassical promoters contain some nucleotide differences that may affect their ability to bind transcription factors. For example, because the SLA-8 promoter lacks an ISRE, IFN may not stimulate the transcription of this gene. We found that constitutive expression from the three classical promoters was highest for SLA-1 and less for SLA-2, whereas SLA-3 showed the least constitutive expression. This is in agreement with results found for PD1 (SLA-1) compared to PD7 (SLA-3; Howcraft and Singer 2003) . In the H01 haplotype, an interspersed repeat or "SINE" separates the enhancer from the silencer of SLA-2 and lengthens the promoter of SLA-3 . The fact that it is absent from the SLA-1 upstream region may explain why this gene is more constitutively active than the others. It is possible that the SINE changes the configuration of the DNA and hinders transcription. Not only does the location of the SINE vary from locus to locus, but also from haplotype to haplotype as described for the H04 (d/d) pig (Maguire et al. 1992) .
The classical SLA 1 promoters showed the greatest response to interferon, in particular, IFN-γ. Nonclassical
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Fold Fig. 6 Transactivation of SLA class I promoters by interferon regulatory factors. a Comparison of ISRE regions from classical and nonclassical SLA promoters with HLA class I genes. b SLA-1 and SLA-7 promoters were co-transfected with pIRF-1 cDNA, pIRF-2 cDNA, pIRF3 cDNA, pIRF 7 cDNA, and pvp16-IRF9 cDNA. IRFs drive the expression of classical but not nonclassical promoters SLA promoters did not respond to interferon despite having homologous ISRE elements. This is consistent with the results for human class I genes, where classical HLA class I genes were transactivated by interferon, but among the nonclassical genes, only the HLA-F gene showed induction by IFN-γ . SLA promoters with truncated inserts comprising isolated elements around the ISRE site alone may show larger interferon induction than those reported here, but isolated elements may be less valid than the context of the whole gene. The response of SLA-1 promoters to coexpression with IRF-1 and IRF-2 cDNAs was less pronounced than the stimulation with added interferon, and this may be because of the induction of PKR and RNase L activity. In keeping with the responses to interferon, the classical SLA-1 promoter, but not the nonclassical SLA 7 promoter, was induced by IRF-3, IRF-7, and IRF-9. Although previous studies on human promoters have shown that transfection of IRF-3 and IRF-7 cDNAs induced IFN-α4 and IFN-α6 promoter activity, the induction of these promoters was much stronger when cells were infected with virus (Marie et al. 1998 classical and nonclassical SLA promoter expression than coexpression with these transcription factors. The enhancer A that binds NF-kB p65 was active in classical SLA but not in nonclassical promoters, shown by TNF-α treatment and cotransfection of NF-kBp65. There is just a one-base pair difference in this site between classical genes and the nonclassical SLA-6 and SLA-8, and two missing bases for SLA-7. This is in line with studies on human enhancer A, where HLA-A and, to a lesser extent, HLA-B are transactivated by NF-κB, but not HLA-F or HLA-G . Transcription of classical SLA class I genes is important in the immediate immune response to infections, whereas nonclassical class I molecules are ubiquitously expressed and not induced after inflammation or infection.
In the human, the SXY module is important in both constitutive and IFN-γ-induced transactivation of HLA class I gene expression, and it is mediated by CIITA (van den Elsen et al. 2004) . CIITA acts as a coactivator of transcription, not binding DNA directly but mediating gene transcription by interacting with the MHC enhanceosome, RFX, CREB, and NF-Y complexes bound to promoter elements X1, X2, and Y, respectively. Our results show that the major induction of classical, but not nonclassical SLA promoters, was by coexpression of CIITA, demonstrating its importance as a transactivator.
The promoter activities of the three classical genes correlate well with a similar study of the human promoter, demonstrating constitutive and cytokine-induced expression, and loci-specific gene expression (Johnson 2003) . Nonclassical promoters do not respond to interferon or inflammatory stimuli. Whereas SLA-1, SLA-2, and SLA-3 molecules are found on most cell types; SLA-7 is more restricted, being high in thymus, but not detected in kidney. SLA-6 was found to be more widespread, although low in brain (Crew et al. 2004 ). In the pig, it is difficult to determine the counterpart of the human nonclassical genes, and the exact function of nonclassical genes has not been elucidated. Comparison of the short motives that have been identified in the promoters may help to answer this; SLA-6 and SLA-7 are more similar to HLA-E and HLA-F than HLA-G.
This study highlights the importance in understanding haplotype and allele-specific differences in modulation of immunity for specific pathogens. It is difficult to define SLA promoter constructs were co-expression CIITA for 48 h. CIITA induces classical but not nonclassical SLA promoter activity differences in surface expression data using antibodies raised against a group of polymorphic molecules with structural homology such as SLA class I. Highly conserved regions such as exon 4 are virtually identical in all class I molecules, including the nonclassical SLA (Crew et al. 2004 ). Many studies showing viral modulation of MHC class I have used monomorphic antibodies for MHC class I analysis (Vallee et al. 2001; Hewitt 2003; Petersen et al. 2003) , but no studies have considered allele-specific differences, or distinguished between classical and nonclassical genes. The promoter-reporter reagents generated in this study will be useful for analysis of the transcriptional regulation of the whole SLA class I family of genes after viral infection.
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